Skip to main content
Clinical Trials/IRCT20221018056229N1
IRCT20221018056229N1
Completed
Phase 3

Investigating the efficacy and safety of platelet rich plasma and topical clobetasol in treating hair loss of patients with lichen planopilaris in comparison to the patients who only use topical clobetasol

Iran University of Medical Sciences0 sites22 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
22
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age: 18 years old and more
  • Definite and resistant hair loss due to LPP
  • The patient gives informed consent
  • The patient can participate in regular follow up meetings
  • The patient does not have serious internal disease
  • The patient does not have cutaneous disease in the site of treatment

Exclusion Criteria

  • History of any remedies taken in last month
  • Positive history of liver, kidney, pulmonary, cardiac, and intestinal disease and malignancies
  • Taking any medications for any disease which makes drug reactions possible
  • Accompanying of LPP with generalized lichen planus or erosive mucosal form
  • Other forms of noncicatricial or other forms of cicatricial alopecia except LPP

Outcomes

Primary Outcomes

Not specified

Similar Trials